Select Equity Group’s Medpace MEDP Stock Holding History

Select Equity Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-187,034	Closed	-$20.9M	–	152
2020 Q3	$20.9M	Buy	+187,034	New	+$21.6M	0.1%	85

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Select Equity Group's MEDP Position: Q4 2020 in Review

Select Equity Group sold out of Medpace (MEDP) in Q4 2020, closing a stake of 187,034 shares — an estimated $20.9M sold.

Select Equity Group first reported a position in MEDP in Q3 2020 and held it in 1 quarter. The position peaked at $20.9M in Q3 2020. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

Select Equity Group reported no remaining Medpace position as of Q4 2020 after selling out during the quarter.
Select Equity Group sold 187,034 Medpace shares in Q4 2020, an estimated $20.9M.
Select Equity Group first reported a position in Medpace in Q3 2020 and held it in 1 quarter.
Select Equity Group's Medpace position peaked at $20.9M in Q3 2020.
316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on Select Equity Group's 13F filing for Q4 2020, filed 16 Feb 2021.